| Financial Year |
March 31 2023 |
| Monetary Funds |
9,421,863,669.83 |
| Held-for-trading Financial Assets |
136,743,177.74 |
| Notes Receivable |
233,549,428.43 |
| Accounts Receivable |
6,649,181,501.02 |
| Advances to Suppliers |
767,002,690.15 |
| Other Receivables |
670,493,687.98 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
6,684,656,635.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
578,010,759.75 |
| Other Current Assets |
736,371,767.13 |
| Total Current Assets |
27,846,980,349.41 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
607,954,635.64 |
| Long-term Equity Investment |
5,948,966,541.49 |
| Investment Properties |
-- |
| Fixed Assetes |
8,682,680,029.98 |
| Under-construction Projects |
1,727,043,023.24 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
4,159,528,700.91 |
| R&D expenses |
1,244,333,723.72 |
| Goodwill |
14,653,707.00 |
| Long-Term Deferred and Prepaid Expenses |
11,734,766.75 |
| Deferred Income Tax Assets |
1,392,730,962.39 |
| Other Non-Current Assets |
328,598,313.77 |
| Sub-Total of Non-Current Assets |
25,878,029,074.17 |
| Total Assets |
53,725,009,423.58 |
| Short-Term Loans |
217,351,252.36 |
| Trading Financial liabilities |
245,389.00 |
| Notes Payable |
7,596,350,144.00 |
| Accounts Payable |
19,071,970,234.50 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
742,383,170.87 |
| Taxes Payable |
381,880,884.85 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,668,076,790.58 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
274,398,964.77 |
| Other Current Liabilities |
336,526,791.47 |
| Sub-Total of Current Liabilities |
34,529,548,829.94 |
| Long-term Loans |
3,973,462,596.39 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,451,000.00 |
| Deferred Income Tax Liabilities |
52,031,411.26 |
| Other Non-Current Liabilities |
428,284,721.31 |
| Sub-Total of Non-Current Liabilities |
5,385,985,061.70 |
| Total Liabilities |
39,915,533,891.64 |
| Paid-In Capital(Or Share Stock) |
8,003,763,475.00 |
| Capital Surplus |
9,550,673,655.90 |
| Surplus Reserve |
2,170,595,382.04 |
| LESS:Treasury Stock |
351,397,742.92 |
| Undistributed Profits |
-5,668,119,502.51 |
| Minority Stockholder's Interest |
211,969,618.11 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,597,505,913.83 |
| Owner's Equity（Stockholder's Equity） |
13,809,475,531.94 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
53,725,009,423.58 |
